These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 32761337)
1. Efficacy and Safety of Guilingji Capsules () for Treating Mild-to-Moderate Cognitive Impairment: Study Protocol for A Randomized, Double-Blind, Positive-Controlled, Multicenter and Noninferiority Trial. Liu NY; Pei H; Liu MX; Liu LT; Fu CG; Li H; Chen KJ Chin J Integr Med; 2020 Aug; 26(8):577-582. PubMed ID: 32761337 [TBL] [Abstract][Full Text] [Related]
2. Guilingji capsule for Alzheimer's disease: secondary analysis of a randomized non-inferiority controlled trial. Ming Z; Yimiao L; Huichan W; Yu C; Lina MA; Hui P; Hao LI J Tradit Chin Med; 2023 Oct; 43(5):1019-1025. PubMed ID: 37679990 [TBL] [Abstract][Full Text] [Related]
3. The Effect of Guilingji Capsules on Vascular Mild Cognitive Impairment: A Randomized, Double-Blind, Controlled Trial. Zhang H; Chen H; Pei H; Wang H; Ma L; Li H Evid Based Complement Alternat Med; 2022; 2022():4778163. PubMed ID: 35116067 [TBL] [Abstract][Full Text] [Related]
4. Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: a randomized, double-blind and parallel-controlled trial. Miao YC; Tian JZ; Shi J; Mao M Zhong Xi Yi Jie He Xue Bao; 2012 Apr; 10(4):390-7. PubMed ID: 22500712 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Yi-Zhi-An-Shen granules on cognition and sleep quality in older adults with amnestic mild cognitive impairment: protocol for a randomized, double-blind, placebo-controlled trial. Yue S; He T; Li B; Qu Y; Peng H; Chen J; Lei M; Chen C; Wu W Trials; 2019 Aug; 20(1):518. PubMed ID: 31429790 [TBL] [Abstract][Full Text] [Related]
6. Effect and Safety of Huannao Yicong Formula () in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Double-Blinded, Donepezil-Controlled Trial. Yang Y; Liu JP; Fang JY; Wang HC; Wei Y; Cao Y; Liu JG; Liu LT; Li H Chin J Integr Med; 2019 Aug; 25(8):574-581. PubMed ID: 30109588 [TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of Fufangdanshen tablets (Radix Salviae miltiorrhizae formula tablets) for mild to moderate vascular dementia: a study protocol for a randomized controlled trial. Tian J; Shi J; Wei M; Qin R; Ni J; Zhang X; Li T; Wang Y Trials; 2016 Jun; 17(1):281. PubMed ID: 27266867 [TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of Jiedu Tongluo granules for treating post-stroke depression with qi deficiency and blood stasis syndrome: study protocol for a randomized controlled trial. Zhao AM; Qiu WR; Mao LJ; Ren JG; Xu L; Yao MJ; Bilinksi K; Chang D; Liu JX Trials; 2018 May; 19(1):275. PubMed ID: 29747670 [TBL] [Abstract][Full Text] [Related]
9. Combination of acupuncture and Chinese herbal formula for elderly adults with mild cognitive impairment: protocol for a randomized controlled trial. Chen Y; Zhang W; Wu H; Lao L; Xu J; Xu S Trials; 2019 Feb; 20(1):117. PubMed ID: 30744676 [TBL] [Abstract][Full Text] [Related]
10. Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT. Clare L; Kudlicka A; Oyebode JR; Jones RW; Bayer A; Leroi I; Kopelman M; James IA; Culverwell A; Pool J; Brand A; Henderson C; Hoare Z; Knapp M; Morgan-Trimmer S; Burns A; Corbett A; Whitaker R; Woods B Health Technol Assess; 2019 Mar; 23(10):1-242. PubMed ID: 30879470 [TBL] [Abstract][Full Text] [Related]
11. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial. De Jesus Moreno Moreno M Clin Ther; 2003 Jan; 25(1):178-93. PubMed ID: 12637119 [TBL] [Abstract][Full Text] [Related]
13. Effects of Chinese medicine for promoting blood circulation and removing blood stasis in treating patients with mild to moderate vascular dementia: a randomized, double-blind and parallel-controlled trial. Wei MQ; Tian JZ; Shi J; Ma FY; Miao YC; Wang YY Zhong Xi Yi Jie He Xue Bao; 2012 Nov; 10(11):1240-6. PubMed ID: 23158942 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of Kami-guibi-tang for mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled trial. Shin HY; Kim HR; Jahng GH; Jin C; Kwon S; Cho SY; Park SU; Jung WS; Moon SK; Ko CN; Park JM BMC Complement Med Ther; 2021 Oct; 21(1):251. PubMed ID: 34620151 [TBL] [Abstract][Full Text] [Related]
15. Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment. Steiner GZ; Bensoussan A; Liu J; Hohenberg MI; Chang DH Trials; 2018 Sep; 19(1):522. PubMed ID: 30253809 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of Yi Shen Fang granules in elderly people with MCI: study protocol for a multicentre, randomized, double-blind, parallel-group, controlled trial. Sha Z; Zhao Z; Li N; Xiao S; Li O; Zhang J; Li Z; Xu J BMC Complement Med Ther; 2023 Apr; 23(1):101. PubMed ID: 37013520 [TBL] [Abstract][Full Text] [Related]
17. The effectiveness and safety of Kami Guibi-tang for mild cognitive impairment: study protocol of a pilot, randomized, placebo-controlled, double-blind trial. Shin HY; Kim JH; Jahng GH; Jung WS; Park SU; Ko CN; Park JM Trials; 2019 Jul; 20(1):448. PubMed ID: 31331367 [TBL] [Abstract][Full Text] [Related]
18. [A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment]. Li H; Yao MJ; Zhao WM; Guan J; Cai LL; Cui L Zhong Xi Yi Jie He Xue Bao; 2008 Jan; 6(1):25-31. PubMed ID: 18184542 [TBL] [Abstract][Full Text] [Related]